Alternative asthma management is generally not helpful Newsletter Article 17 February 2013 Pages: 4 - 4
Guidelines for assessing clinical study subgroup differences Newsletter Article 17 February 2013 Pages: 5 - 5
Fenoterol and asthma deaths - study design criticised Newsletter Article 17 February 2013 Pages: 5 - 6
Academic presentations lead to cost-effective prescribing Newsletter Article 17 February 2013 Pages: 7 - 7
Pharmacoeconomic analyses of biotechnology products needed Newsletter Article 17 February 2013 Pages: 7 - 8
‘Oxandrin’ now available in the USA under IND status Newsletter Article 17 February 2013 Pages: 8 - 8
Products in the R&D pipeline - After the damage is done … Newsletter Article 17 February 2013 Pages: 9 - 10
Latin American praise for Schering’s combined injectable contraceptive Newsletter Article 17 February 2013 Pages: 10 - 11
Omeprazole superior to placebo in erosive oesophagitis Newsletter Article 17 February 2013 Pages: 11 - 11
Perennial allergic rhinitis in children - relieved by triamcinolone Newsletter Article 17 February 2013 Pages: 11 - 11
The alteplase myth and the future of thrombolytics Newsletter Article 17 February 2013 Pages: 12 - 13
One dose of pamidronic acid beats 3 of etidronic acid Newsletter Article 17 February 2013 Pages: 13 - 13
Endoscopic therapy is beneficial in upper GI haemorrhage Newsletter Article 17 February 2013 Pages: 13 - 14
Improved detection of epoetin-induced iron deficiency Newsletter Article 17 February 2013 Pages: 19 - 19